Vitamin D decreases risk of severe asthma attacks, research finds

6 September 2016
cochrane-large

Adding vitamin D to medication reduces the likelihood of severe asthma attacks, according to research group the Cochrane Library.

The UK-based body – made up of a global network of researchers, professionals, patients, carers and more -, gathers and summarizes evidence from its contributors to help to make health decisions.

Its new review, titled Vitamin D for the management of asthma, noted that low blood levels of what is known as the ‘sunshine vitamin’ had been linked to increased attacks in children and adults with the condition.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical